Accolade, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2021
January 10, 2022 at 04:05 pm
Share
Accolade, Inc. reported earnings results for the third quarter and nine months ended November 30, 2021. For the third quarter, the company reported sales was USD 83.45 million compared to USD 38.44 million a year ago. Net income was USD 22.5 million compared to net loss of USD 16.6 million a year ago. Basic earnings per share from continuing operations was USD 0.34 compared to basic loss per share from continuing operations of USD 0.32 a year ago. Diluted earnings per share from continuing operations was USD 0.31 compared to diluted loss per share from continuing operations of USD 0.32 a year ago.
For the nine months, sales was USD 216.27 million compared to USD 111.13 million a year ago. Net loss was USD 88.57 million compared to USD 45.93 million a year ago. Basic loss per share from continuing operations was USD 1.41 compared to USD 1.5 a year ago. Diluted loss per share from continuing operations was USD 1.41 compared to USD 1.5 a year ago.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.